Most efforts to identify genetic mutations associated with TD risk have centered on nuclear genes which mutations in IMMP2L, CNTNAP2, SLITRK1, NLGN4X, and MRPL3 have been linked to TD risk [6–10]. The gene discussed is IMMP2L; the disease is thanatophoric dysplasia.